Rita Keynan

Corporate Officer/Principal presso PAINREFORM LTD.

Health Technology

Consumer Services

Posizioni attive di Rita Keynan

Società	Posizione	Inizio	Fine
PAINREFORM LTD.	Corporate Officer/Principal	06/01/2021	-

Società	Posizione	Inizio	Fine
VYNE Pharmaceuticals Ltd. VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.	Corporate Officer/Principal	-	-

The Hebrew University of Jerusalem

Graduate Degree

Distribuzione geografica

Israele

Posizioni

Corporate Officer/Principal	2
Graduate Degree	1
Undergraduate Degree	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
PAINREFORM LTD.	Health Technology

Aziende private	1
VYNE Pharmaceuticals Ltd. VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.	Health Technology

Aziende private

Health Technology